About
Misonix, Inc. is a New York-based company that designs, develops, manufactures, and markets minimally invasive ultrasonic surgical devices and regenerative medicine technologies. Founded in 1955, Misonix has established itself as a leader in ultrasonic technology, particularly in therapeutic devices used across various clinical specialties, including spine surgery, neurosurgery, and orthopedic surgery. Key products include the BoneScalpel® Surgical System for precise bone shaping, the SonaStar® Surgical Aspirator for tumor removal, and the SonicOne® Wound Cleansing and Debridement System for effective wound care. Misonix also offers the Sonablate 500, which utilizes High Intensity Focused Ultrasound (HIFU) technology for treating prostate cancer and benign tumors. The company serves healthcare providers worldwide, including hospitals and surgical centers. In October 2021, Misonix became a wholly owned subsidiary of Bioventus Inc., enhancing its reach and integrating its ultrasonic platforms with Bioventus’s regenerative medicine products. This partnership aims to improve clinical outcomes and expand the customer base in various medical fields.
Technologies
Keywords
Company Information
-
Employees 290
-
Founded 1959
-
Annual Revenue $74024000
-
Total Funding $5199487
Location
1938 New Highway, Farmingdale, New York, United States, 11735